Sep 1, 2026 09:07AM
Aug 31, 2026 06:04AM
Aug 30, 2026 08:23AM
Aug 24, 2026 08:33AM
Aug 24, 2026 08:33AM
Jul 30, 2026 08:00AM
Apr 30, 2026 08:00AM Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
Mar 30, 2026 01:00PM
Mar 30, 2026 01:00PM
Mar 24, 2026 07:30AM
Mar 24, 2026 07:30AM
Mar 10, 2026 08:00AM
Feb 19, 2026 08:30AM
Feb 12, 2026 08:00AM Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
Dec 21, 2025 04:00AM
Dec 17, 2025 08:02AM
Dec 17, 2025 08:00AM
Nov 8, 2025 04:57PM
Nov 8, 2025 04:57PM
Oct 30, 2025 08:00AM
Oct 10, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 1, 2025 07:30AM
Oct 1, 2025 07:30AM
Sep 29, 2025 06:58PM
Sep 28, 2025 11:13AM
Sep 28, 2025 11:13AM
Sep 28, 2025 11:13AM
Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM
Aug 30, 2025 10:30AM Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
Aug 11, 2025 08:00AM
Jul 31, 2025 08:00AM
Jun 9, 2025 06:00AM
Jun 9, 2025 06:00AM
May 17, 2025 05:50AM
May 1, 2025 08:00AM
Apr 28, 2025 08:00AM Alnylam Pharma (ALNY) Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Apr 28, 2025 08:00AM
Apr 12, 2025 04:00AM
Apr 11, 2025 09:44AM
Apr 10, 2025 05:32AM
Mar 31, 2025 05:21AM
Mar 29, 2025 01:00PM
Mar 28, 2025 04:45PM Alnylam Pharma (ALNY) Announces FDA Approval of Qfitlia
Mar 28, 2025 04:44PM

331,812 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All